Company: IPHYF
Filing Date: 2025-04-30
Form Type: 20-F
Source: 0001598599-25-000042
Chunk: 229

Company: Innate Pharma SA
Filing Date: 2025-04-30
Form: 20-F
Item: Item 6
Chunk 229
---
 of attendance fees among the Supervisory Board and the committees members;

• assisting the Supervisory Board in the selection of the members of the Executive Board and committees; and

• making recommendations with respect to the independence of the members of the Supervisory Board and committees and preventing conflicts of interest within the Supervisory Board.

Transactions Committee

Innate's Transactions Committee assists the Supervisory Board in examining the business and corporate development opportunities available to us, which may include the acquisition of rights to products or the acquisition of other companies as well as out-licensing opportunities. As of December 31, 2024, the members of this committee are Irina Staatz-Granzer, Bpifrance and Gilles Brisson. Currently, Irina Staatz-Granzer is an independent member and Chairman of the Transactions Committee.

Innate Pharma's Supervisory Board has specifically assigned the following duties to the Transactions Committee:

• to analyze the fundamentals of the products and/or companies targeted by us, the feasibility of targeted acquisitions; and

• to participate in the selection of investment bankers and/or consultants.

CSR Committee

The Supervisory Board of September 14, 2022, on the recommendation of the Compensation and Nomination Committee of September 12, 2022, decided to set up a CSR Committee. The first meeting of the committee was held on July 5, 2023.

As of December 31, 2024, the members of the CSR Committee are Sally Bennett, Véronique Chabernaud, Irina Staatz-Granzer and Olivier Martinez.

The main duties of the CSR Committee are to:

• make recommendations on the CSR policy and its implementation by the Company;

• examine the content of the non-financial information;

• review the Company's CSR publications; and

• determine the CSR criteria for the annual and multi-annual variable remuneration.

Other Committees

The Strategic Advisory Board

The Company also has a Strategic Advisory Board composed of six external consultants, consisting of three individuals from the medical community and three individuals from the scientific community. The Strategic Advisory Board is not a committee of the Supervisory Board within the meaning of Article R.225-29 of the French Commercial Code; its members are chosen by the Executive Board. This kind of advisory committee is common in French companies in the biotechnology sector.

The Strategic Advisory Board’s role is to assist Innate in the strategic choices in scientific and technical fields. Its main missions are to evaluate the relevance of the choices in terms of product development